Soleno Therapeutics posts Q3 profit as VYKAT XR adoption grows, doubling revenue. Learn about EU expansion plans, analyst concerns, and future outlook.

Pfizer Inc. (NYSE: PFE) today issued the following statement in response to the Delaware Chancery Court's decision denying Pfizer's request for a temporary restraining order to prevent Metsera, Inc.

CERo Therapeutics Holdings, Inc., (OTC PINK: CERO) ('CERo” or the 'Company”), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanisms, announces the ...

Detailed price information for Phio Pharmaceuticals Corp (PHIO-Q) from The Globe and Mail including charting and trades.

Q3 2025 Earnings Call Transcript November 4, 2025 InspireMD, Inc. beats earnings expectations. Reported EPS is $0.4262, ...

Rayonier Inc. (NYSE:RYN) today reported third quarter net income attributable to Rayonier of $43.2 million, or $0.28 per ...

Milestone advances two-part study evaluating novel, locally administered gene therapy designed to increase anti-inflammatory ...

Informatica (NYSE: INFA), a leader in enterprise AI-powered cloud data management, today announced financial results for its ...

CELEBRATION, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with ...

Q3 2025 Earnings Call Transcript November 4, 2025 Taysha Gene Therapies, Inc. misses on earnings expectations. Reported EPS ...

Justice Neena Bansal Krishna said, "This is clearly not the mandate for the media, which owes the responsibility of not only making correct information available to the public but also ensure that ...

Revenue of $53.1 million , up 5% year over year , above the midpoint of guidancePositive adjusted EBITDA of $1.1 million or 2% adjusted EBITDA ...